Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikao Morimoto

Showing results (11-20 of 146) with videos related to

Pageof 15
Sort By:
Modern Rheumatology|December 5, 2006
Selective modulation of glucocorticoid receptor function toward development of novel anti-inflammation: lessons from a phenyl-pyrazolo-steroid cortivazolHirotoshi Tanaka, Noritada Yoshikawa, Noriaki Shimizu, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Could serum antibody to poly(ADP-ribose) and/or histone H1 be marker for senile dementia of Alzheimer type?Yoshiyuki Kanai, Hiroyasu Akatsu, Hideki Iizuka, et al.
Modern Rheumatology|October 5, 2018
Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapyKei Ohnuma, Ryo Hatano, Nam H Dang, et al.
Advances in Clinical Chemistry|March 17, 2011
Dipeptidyl peptidase in autoimmune pathophysiologyKei Ohnuma, Osamu Hosono, Nam H Dang, et al.
Modern Rheumatology|January 7, 2014
CD26: a key molecule in immune regulation and autoimmune diseasesOsamu Hosono, Kei Ohnuma, Nam H Dang, et al.
Cureus|March 29, 2021
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological FunctionsKelsey Pan, Kei Ohnuma, Chikao Morimoto, et al.
Blood Cancer Journal|October 24, 2018
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myelomaHiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, et al.
Biochemical and Biophysical Research Communications|March 26, 2013
Multiple effects of repetitive transcranial magnetic stimulation on neuropsychiatric disordersTetsurou Ikeda, Masaru Kurosawa, Chikao Morimoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5Katsuaki Sato, Hiroshi Kawasaki, Chikao Morimoto, et al.
Biochemical and Biophysical Research Communications|April 4, 2009
CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cellsHiroto Yamazaki, Hiroko Nishida, Satoshi Iwata, et al.
Pageof 15

Showing results (11-20 of 146) with videos related to

Sort By:
Pageof 15
Modern Rheumatology|December 5, 2006
Selective modulation of glucocorticoid receptor function toward development of novel anti-inflammation: lessons from a phenyl-pyrazolo-steroid cortivazolHirotoshi Tanaka, Noritada Yoshikawa, Noriaki Shimizu, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Could serum antibody to poly(ADP-ribose) and/or histone H1 be marker for senile dementia of Alzheimer type?Yoshiyuki Kanai, Hiroyasu Akatsu, Hideki Iizuka, et al.
Modern Rheumatology|October 5, 2018
Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapyKei Ohnuma, Ryo Hatano, Nam H Dang, et al.
Advances in Clinical Chemistry|March 17, 2011
Dipeptidyl peptidase in autoimmune pathophysiologyKei Ohnuma, Osamu Hosono, Nam H Dang, et al.
Modern Rheumatology|January 7, 2014
CD26: a key molecule in immune regulation and autoimmune diseasesOsamu Hosono, Kei Ohnuma, Nam H Dang, et al.
Cureus|March 29, 2021
CD26/Dipeptidyl Peptidase IV and Its Multiple Biological FunctionsKelsey Pan, Kei Ohnuma, Chikao Morimoto, et al.
Blood Cancer Journal|October 24, 2018
CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myelomaHiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, et al.
Biochemical and Biophysical Research Communications|March 26, 2013
Multiple effects of repetitive transcranial magnetic stimulation on neuropsychiatric disordersTetsurou Ikeda, Masaru Kurosawa, Chikao Morimoto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5Katsuaki Sato, Hiroshi Kawasaki, Chikao Morimoto, et al.
Biochemical and Biophysical Research Communications|April 4, 2009
CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cellsHiroto Yamazaki, Hiroko Nishida, Satoshi Iwata, et al.
Pageof 15